Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

NCT02082457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome
Constipation

Interventions

DRUG: YKP10811 5mg
DRUG: YKP10811 20mg
DRUG: YKP10811 placebo

Sponsor

SK Chemicals Co., Ltd.